Chicago, IL  /  E-commerce, B2B and AI search, nationwide Case studies Free audit (708) 289-1530
Chicago SEO AgencyE-commerce · B2B · AI

Built for catalogs

Wholesale, distribution, and manufacturing search work differently than retail. See how we approach it.

All industries
MINNESOTA

Minnesota SEO company for companies whose copy has to clear review.

Medical device, medical supply and food manufacturing dominate this state, and all three share a constraint most SEO advice ignores. You cannot publish freely. Every claim goes through somebody whose job is to say no.

Regulated copyClaims disciplineMedical deviceFood manufacturing
Minnesota SEO company for medical device and regulated manufacturers.
The real constraint

Write to the boundary, not against it.

The left column is how content usually gets made in regulated companies. It is also why most of those programmes quietly stop after a year.

Area
Usual approach
How we do it
When review happens
At the end, on a finished draft
At the brief, before anything is written
What review produces
Heavy markup and rework
Minor edits on a compliant first draft
What publishes
Vague copy that survived
Specific copy that was always inside the line
Who writes the brief
Marketing alone
Marketing with regulatory input
Cycle time
Long, because of rework
Shorter overall, despite more upfront
Outcome after a year
Programme abandoned
A library of publishable, specific pages
The approach

Four changes that make content survivable here.

None of these involve pushing the boundary. They involve knowing where it is before you start.

01

Establish the boundary first

A short session with regulatory on what can and cannot be claimed for each product family, captured as a written brief the writer works inside.

02

Be specific about everything else

Specification, materials, compatibility, sterilisation, shelf life, standards conformance and instructions for use. None of it needs a claim and all of it is searched.

03

Cite rather than assert

Where published evidence exists and is cleared for that use, citing it accurately is usually safer than the marketing language people reach for instead.

04

Build a reusable approved library

Cleared phrasing, standard descriptions and approved claim language captured once and reused, so each new page starts closer to approved than the last.

Regulated production and packaging in a Minnesota facility.
What is publishable without a claim

Most of what buyers search does not require one.

This is the part that surprises companies who have concluded they cannot do content. The searches that bring in qualified clinical and procurement buyers are overwhelmingly specification and process questions rather than efficacy questions.

  • Dimensions, materials, tolerances and configurations
  • Compatibility with systems, instruments and consumables
  • Sterilisation method, shelf life, storage and handling
  • Regulatory status and standards conformance, stated factually
  • Instructions for use and technique guidance where cleared
  • Packaging, pack size, ordering codes and availability
1,200+ In this state, the constraint is the default condition.Minnesota's Department of Employment and Economic Development counts more than 1,200 medical technology companies in the state, with 95 percent of the medtech ecosystem located inside a 50 kilometre radius, alongside 17 Fortune 500 companies. Regulated copy is not an edge case here. It is how most of the state markets anything.Source: Minnesota Department of Employment and Economic Development Medical supply SEO
What regulated buyers search

Specification and process, not efficacy.

Almost none of these require a claim to answer, which is why the constraint is far less limiting than it feels.

Specification and compatibility

The core of a regulated catalog.

  • [product] dimensions and sizes
  • is [product] compatible with [system]
  • [product] material composition
  • sterilisation method for [product]

Procedure and technique

Where a clinical buyer actually starts.

  • instruments needed for [procedure]
  • setup for [procedure type]
  • how to prepare [product] for use
  • [technique] step by step

Regulatory and standards

Pass or fail, searched directly.

  • fda cleared [device category]
  • iso 13485 certified manufacturer
  • ce marked [product type]
  • [standard] compliant [product]

Sourcing and supply

Procurement, and rarely answered.

  • [product] ordering codes
  • distributor for [brand] [product]
  • lead time for [product category]
  • contract pricing [product type]
Why the usual process fails

Nobody involved is doing anything wrong.

The failure mode in regulated content is remarkably consistent and it is not caused by anybody being difficult. Marketing writes a page the way they would write any page, aiming to be persuasive. Regulatory reviews it against what can actually be substantiated and marks up everything that cannot. Marketing rewrites, hedging every statement to get it through. What finally publishes is technically compliant and says almost nothing.

Repeat that for six months and two things happen. The content does not rank, because vagueness ranks for nothing. And the organisation concludes that content marketing does not work for regulated products, which is the wrong lesson from an accurate observation.

The fix is a sequencing change rather than a policy change. Establish what can be claimed for a product family before anybody writes a sentence. Capture it as a brief. Then write inside it, being as specific as possible about everything the boundary does not touch, which turns out to be most of what buyers actually search for.

Companies that make this change usually report the same two effects. Review cycles get shorter, because the first draft is close to compliant. And the published content gets more specific rather than less, because nobody is hedging language that was never going to be a problem.

Medical device manufacturing and inspection in Minnesota.
07
Who this fits

Three kinds of company in this state with the same constraint.

The rules differ across these categories and the discipline is identical: know the boundary, then be relentlessly specific about everything outside it.

  • Medical device manufacturers, where claims track what has been cleared
  • Medical supply and distribution, where labelling and indication apply
  • Food and beverage manufacturers, facing labelling and claim rules
  • Contract manufacturers serving any of the above
  • Anybody whose marketing copy currently goes to a reviewer before it goes live
AI answers

Specification questions are ideal assistant territory.

Is this compatible, what is it made of, how is it sterilised, what is cleared for what. These are exactly what assistants get asked, and they answer from published factual content rather than from claim language.

  • Specification and compatibility published as plain factual text
  • Regulatory status stated accurately rather than implied
  • Instructions for use and technique guidance where cleared
  • Consistent product facts across your site, distributors and listings
Related work

Where a Minnesota program goes.

Most regulated manufacturers here need at least one of these.

All industries
In one line

Minnesota SEO written to clear review the first time, which turns out to produce more specific content rather than less.

Questions

Regulated content, answered.

An audit looks at what your review process is currently costing you in cycle time and in specificity.

Talk to a strategist
Why does regulatory review break most content programmes?
Because the usual process produces copy first and reviews it last. Everything comes back marked up, the writer rewrites toward vagueness to get it approved, and what publishes says nothing. Six months of that and everyone concludes content does not work here.
What is the alternative?
Write to the constraint from the brief rather than against it at the end. If you know what can be claimed before anybody writes a sentence, the first draft clears review largely intact and the content stays specific.
Does that not just produce cautious content?
The opposite, in our experience. Vagueness is what happens when marketing writes freely and review strips it back. Writing inside a known boundary from the start lets you be extremely specific about everything the boundary does not cover, which is most of what buyers search.
What can be published without a claim?
Specification, materials, dimensions, compatibility, sterilisation method, shelf life, packaging, regulatory status, standards conformance and instructions for use. That is most of what a clinical buyer or a procurement team actually searches for.
How large is this sector in Minnesota?
Very. Minnesota's Department of Employment and Economic Development counts more than 1,200 medical technology companies in the state's Medical Alley, with 95 percent of the medtech ecosystem inside a 50 kilometre radius. The regulatory constraint is not a niche problem here, it is the default condition.
Does the same apply to food manufacturing?
Yes, with different rules and the same shape. Labelling, health claims and structure function claims are all regulated, and the same discipline applies: know what is sayable before writing rather than after.
Should regulatory be involved earlier or will that slow things down?
Earlier, and it usually speeds things up. A twenty minute conversation about what can be claimed before a brief is written saves multiple review cycles later. The delay in these programmes is almost always rework rather than review itself.
Can we publish clinical evidence?
Where it exists, is cleared for that use and is presented accurately, generally yes, and it is worth doing because almost nobody does. Citing published literature accurately is usually far safer than the marketing language people reach for instead.
How is this different from your New Jersey approach?
Different constraint entirely. New Jersey is about confidentiality, meaning what you can say about the customers you make things for. This is about regulatory review, meaning what you can claim about the product itself. Some companies face both.
How long does content take to produce under this process?
Slower per page and faster overall, because the rework disappears. Expect the first few pieces to take longer while the boundary gets established, then a noticeably smoother pipeline than the write-then-fight approach.
Prefer to just talk it through?No forms, no gatekeeping. Call and you get someone who does the work.

Tell us what you sell. We will tell you what is possible.

Two minutes now, a straight answer back within one business day. No obligation and no sales sequence.

Rather talk?
(708) 289-1530
Please add your name.
Please add a valid email address.
A sentence or two is plenty.

Goes straight to contact@chicagoseoagency.co. We reply within one business day.

See what you can publish without a claim.

We map the demand around your products against what can be said factually, and show you how much of it needs no claim at all.

Call Get a proposal